---
schema_version: "secwatch.filing_event.v1"
accession: "0001779372-22-000010"
form_type: "8-K"
ticker: "BEAT"
cik: "0001779372"
company_name: "HeartBeam, Inc."
filed_at: "2022-03-10T23:59:59+00:00"
generated_at: "2026-06-27T00:04:03.953042+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# HeartBeam partners with Triple Ring to co-develop 3D vector ECG device; FDA submission targeted by Q4 2022

## Summary
- Five-phase expedited project includes device builds for verification, validation, packaging and manufacturing transfer.
- Credit card-sized 3D vector ECG recorder via smartphone app; cloud-based diagnostic suggestion and 12-lead synthesis.
- Targeting FDA 510(k) submission in Q4 2022; discussions with contract manufacturers underway.
- Triple Ring brings medtech co-development expertise from early R&D through regulatory approval and commercialization.

## SEC filing metadata
- accession: 0001779372-22-000010
- form_type: 8-K
- ticker: BEAT
- cik: 0001779372
- company_name: HeartBeam, Inc.
- filed_at: 2022-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1779372/000177937222000010/0001779372-22-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1779372/000177937222000010/beat-20220307.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001779372-22-000010
- JSON: https://secwatch.observer/filing/0001779372-22-000010.json
- Plain text: https://secwatch.observer/filing/0001779372-22-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.